Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Novavax, Inc. (NASDAQ: NVAX) closed at $12.97 up 1.89% from its previous closing price of $12.73. In other words, the price has increased by $1.89 from its previous closing price. On the day, 3.74 million shares were traded. NVAX stock price reached its highest trading level at $13.12 during the session, while it also had its lowest trading level at $12.56.
Ratios:
For a deeper understanding of Novavax, Inc.’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.88 and its Current Ratio is at 0.90.
On May 10, 2024, BofA Securities Upgraded its rating to Neutral which previously was Underperform and also upped its target price recommendation from $4 to $12.
B. Riley Securities Upgraded its Neutral to Buy on August 09, 2023, while the target price for the stock was maintained at $15.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 21 ’24 when YOUNG JAMES F sold 7,500 shares for $14.09 per share. The transaction valued at 105,675 led to the insider holds 61,760 shares of the business.
YOUNG JAMES F sold 7,500 shares of NVAX for $102,881 on Jun 18 ’24. The Director now owns 69,260 shares after completing the transaction at $13.72 per share. On Jun 17 ’24, another insider, Dubovsky Filip, who serves as the President, R&D of the company, sold 13,904 shares for $14.47 each. As a result, the insider received 201,164 and left with 66,613 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NVAX now has a Market Capitalization of 1910455040 and an Enterprise Value of 1921502080. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.83. Its current Enterprise Value per Revenue stands at 1.928 whereas that against EBITDA is -5.756.
Stock Price History:
The Beta on a monthly basis for NVAX is 1.98, which has changed by 0.76222825 over the last 52 weeks, in comparison to a change of 0.23886502 over the same period for the S&P500. Over the past 52 weeks, NVAX has reached a high of $23.86, while it has fallen to a 52-week low of $3.53. The 50-Day Moving Average of the stock is 10.60%, while the 200-Day Moving Average is calculated to be 84.91%.
Shares Statistics:
For the past three months, NVAX has traded an average of 15.82M shares per day and 9970310 over the past ten days. A total of 139.51M shares are outstanding, with a floating share count of 133.33M. Insiders hold about 5.04% of the company’s shares, while institutions hold 56.89% stake in the company. Shares short for NVAX as of 1718323200 were 39708110 with a Short Ratio of 2.51, compared to 1715731200 on 45291396. Therefore, it implies a Short% of Shares Outstanding of 39708110 and a Short% of Float of 34.36.
